Extracellular processing and presentation of a 69-mer synthetic polypeptide to MHC class I-restricted T cells

Molecular Immunology

Volumn 36, Issue 2, 1999, Pages 103-112

  Eberl, G ^a   Renggli, J ^a   Men, Y ^a   Roggero, M A ^a   Lopez, J A ^a   Corradin, G ^a  

^a NONE

Author keywords

CTL; MHC; Peptide; Presentation; Processing

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EXTRACELLULAR SPACE; FEMALE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, PROTOZOAN; EPITOPES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; KINETICS; MICE; MICE, INBRED BALB C; PEPTIDES; PLASMODIUM BERGHEI; PROTEIN PROCESSING, POST-TRANSLATIONAL; T-LYMPHOCYTES;

ANIMALIA; PLASMODIUM BERGHEI;

EID: 0033049650     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(99)00023-1     Document Type: Article

References (59)

1. + cytotoxic T cells. J. Exp. Med. 172:1990;1083-1090.
2. Alving C.R., Koulchin V., Glenn G.M., Rao M. Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides. Immunol. Rev. 145:1995;5-31.
3. Amigorena S., Drake J.R., Webster P., Mellman I. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature (Lond.). 369:1994;113-120.
4. Atherton E., Logan C.J., Sheppard R.C. Procedures for solid phase synthesis using Na-fluorenylmethoxycarbonylamino-acids on polyimide supports. Synthesis of substance P and of acyl carrier protein 65-74 decapeptide. J. Chem. Soc., Perkin Trans. 1:1981;538-546.
5. Bevan M.J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143:1976;1283-1288.
6. Blum-Tirouvanziam U., Beghdadi-Rais C., Roggero M.A., Valmori D., Bertholet S., Bron C., Fasel N., Corradin G. Elicitation of specific cytotoxic T cells by immunization with malaria soluble synthetic polypeptides. J. Immunol. 153:1994;4134-4141.
7. + T cells requires secretion of hemolysin and intracellular bacterial growth. J. Immunol. 145:1990;3540-3546.
8. Cerami C., Frevert U., Sinnis P., Takacs B., Clavijo P., Santos M.J., Nussenzweig V. The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites. Cell. 70:1992;1021-1033.
9. Cerundolo V., Alexander J., Anderson K., Lamb C., Cresswell P., McMichael A., Gotch F., Townsend A. Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature (Lond.). 345:1990;449-452.
10. Debrick J.E., Campbell P.A., Staerz U.D. Macrophages as accessory cells for class I MHC-restricted immune responses. J. Immunol. 147:1991;2846-2851.
11. Deres K., Schild H., Wiesmüller K-H., Jung G., Rammensee H-G. In vivo priming of virus-specific cytotoxic lymphocytes with synthetic lipopeptide vaccine. Nature (Lond.). 342:1989;561-564.
12. Driscoll J., Brown M.G., Finley D., Monaco J.J. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature (Lond.). 365:1993;262-264.
13. Eisenlohr L.C., Bacik I., Bennink J.R., Bernstein K., Yewdell J.W. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes. Cell. 71:1992;963-972.
14. Germain R.N., Margulies D.H. The biochemistry and cell biology of antigen processing and presentation. Ann. Rev. Immunol. 11:1993;403-450.
15. Harding C.V., Song R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153:1994;4925-4933.
16. Hosmalin A., Kumar S., Barnd D., Houghten R., Smith G.E., Hugh S.H., Berzofsky J.A. Immunization with soluble protein-pulsed spleen cells induces class I-restricted cytotoxic T lymphocytes that recognize immunodominant epitopic peptides from Plasmodium falciparum and HIV-1. J. Immunol. 149:1992;1311-1318.
17. Jackson M.R., Cohen-Doyle M.F., Peterson P.A., Williams D.B. Regulation of MHC class I transport by the molecular chaperone, calnexin. Science. 263:1994;384-387.
18. Jondal M., Schirmbeck R., Reinmann J. MHC class I-restricted CTL responses to exogenous antigens. Immunity. 5:1996;295-302.
19. Kelly A., Powis S.H., Kerr L.A., Mockridge I., Elliott T., Bastin J., Uchanska-Ziegler B., Ziegler A., Trowsdale J., Townsend A. Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature (Lond.). 355:1992;641-644.
20. Kovacsovics-Bankowski M., Clark K., Benacerraf B., Rock K.L. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA. 90:1993;4942-4946.
21. Kozlowski S., Corr M., Takeshita T., Boyd L.F., Pendleton C.D., Germain R.N., Berzofsky J.A., Margulies D.H. Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules. J. Exp. Med. 175:1992;1417-1422.
22. Lanar D.E. Sequence of the circumsporozoite gene of Plasmodium berghei ANKA clone and NK65 strain. Molec. Bioch. Parasitol. 39:1990;151-154.
23. Li Z., Srivastava P.K. Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation. EMBO Journal. 12:1993;3143-3151.
24. Liu T., Zhou X., Orvell C., Lederer E., Ljunggren H.G., Jondal M. Heat-inactivated Sendai virus can enter multiple MHC class I processing pathways and generate cytotoxic T lymphocyte responses in vivo. J. Immunol. 154:1995;3147-3155.
25. Lopez J.A., Roggero M.A., Duombo O., Gonzalez J.M., Tolle F., Koita O., Arevalo-Herrera M., Herrera S., Corradin G. Recognition of synthetic 104-mer and 102-mer peptides corresponding to N- and C-terminal nonrepeat regions of the Plasmodium falciparum cirumsporozoite protein by sera from human donors. Am. J. Trop. Med. Hyg. 55:1996;424-429.
26. Maryanski J.L., Pala P., Cerottini J-C., Corradin G. Synthetic peptides as antigens and competitors in recognition by H-2-restricted cytolytic T cells specific for HLA. J. Exp. Med. 167:1988;1391-1405.
27. + T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. J. Exp. Med. 178:1993;889-899.
28. Milich D.R. Synthetic T- and B-cell recognition sites: Implications for vaccine development. Adv. Immunol. 45:1989;195-282.
29. Monaco J.J. Major histocompatibility complex-linked transport proteins and antigen processing. Immunol. Res. 11:1992;125-132.
30. Nair S., Buiting A.M., Rouse R.J., Van Rooijen N., Huang L., Rouse B.T. Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. Int. Immunol. 7:1995;679-688.
31. Norbury C.C., Hewlett L.J., Prescott A.R., Shastri N., Watts C. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity. 3:1995;783-791.
32. Nuchtern J.G., Bonifacino J.S., Biddison W.E., Klausner R.D. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation. Nature (Lond.). 339:1989;223-226.
33. Ortmann B., Androlewicz M.J., Cresswell P. MHC class I/beta 2-microglobulin complexes associate with TAP transporters before peptide binding. Nature (Lond.). 368:1994;864-867.
34. Otten G.R., Bikoff E., Ribaudo R.K., Kozlowski S., Margulies D.H., Germain R.N. Peptide and β2-microglobulin regulation of cell surface MHC class I conformation and expression. J. Immunol. 148:1992;3723-3732.
35. Paglia P., Chiodoni C., Rodolfo M., Colombo M.P. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183:1996;317-322.
36. Parker D.C. T-cell dependent B-cell activation. Ann. Rev. Immunol. 11:1993;331-360.
37. Roggero M.A., Filippi B., Church P., Hoffman S.L., Blum-Tirouvanziam U., Lopez J.A., Esposito F., Matile H., Reymond C.D., Fasel N., Corradin G. Synthesis and immunological characterization of 104-mer and 102-mer peptides corresponding to the N- and C-terminal regions of the Plasmodium falciparum CS protein. Mol. Immunol. 32:1995;1301-1309.
38. Romero P., Maryanski J.L., Corradin G., Nussenzweig R.S., Nussenzweig V., Zavala F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature (Lond.). 341:1989;323-326.
39. d-restricted antigenic peptides share a simple binding motif. J. Exp. Med. 174:1991;603-612.
40. Romero P., Eberl G., Casanova J-L., Cordey A-S., Widmann C., Luescher I.F., Corradin G., Maryanski J.L. Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. J. Immunol. 148:1992;1871-1878.
41. + cytotoxic T lymphocytes in mice. Eur. J. Immunol. 22:1992;759-766.
42. Schirmbeck R., Bohm W., Reimann J. Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T-cells in vivo. Eur. J. Immunol. 24:1994;2068-2072.
43. + cytotoxic T lymphocyte responses in vivo. J. Immunol. 152:1994;1110-1119.
44. Schirmbeck R., Bohm W., Melber K., Reimann J. Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation. J. Immunol. 155:1995;4676-4684.
45. Schwartz R.H. Immune response (Ir) genes of the murine major histocompatibility complex. Adv. Immunol. 38:1987;31-201.
46. Shepherd J.C., Schumacher T.N., Ashton-Rickardt P.G., Imaeda S., Ploegh H.L., Janeway C.A. Jr, Tonegawa S. TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell. 74:1993;577-584.
47. Sherman M.A., Weber D.A., Jensen P.E. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity. 3:1995;197-205.
48. Song R., Harding C.V. Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. J. Immunol. 156:1996;4182-4190.
49. Suh W.K., Mitchell E.K., Yang Y., Peterson P.A., Waneck G.L., Williams D.B. MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains. J. Exp. Med. 184:1996;337-348.
50. + T lymphocytes by vaccination with nonliving bacteria. Proc. Natl. Acad. Sci. USA. 92:1995;12,389-12,392.
51. Tulp A., Verwoerd D., Dobberstein B., Ploegh H.L., Pieters J. Isolation and characterization of the intracellular MHC class II compartment. Nature (Lond.). 369:1994;120-126.
52. Vitiello A., Potter T.A., Sherman L.A. The role of β2-microglobulin in peptide binding by class I molecules. Science. 250:1990;1423-1426.
53. + T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. USA. 85:1988;573-576.
54. West M.A., Lucocq J.M., Watts C. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature (Lond.). 369:1994;147-151.
55. Widmann C., Maryanski J.L., Romero P., Corradin G. Differential stability of antigenic MHC class I-restricted synthetic peptides. J. Immunol. 147:1991;3745-3751.
56. Widmann C., Romero P., Maryanski J.L., Corradin G., Valmori D. T-helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides. J. Immunol. Methods. 155:1992;95-99.
57. Wu J.Y., Gardner B.H., Kushner N.N., Pozzi L.A., Kensil C.R., Cloutier P.A., Coughlin R.T., Newman M.J. Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T lymphocytes. Cell. Immunol. 154:1994;393-406.
58. Yewdell J.W., Bennink J.R., Hosaka Y. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science. 239:1988;637-640.
59. Zinkernagel R.M., Doherty P.C. MHC-restricted cytotoxic T cells: studies on the biological role of the polymorphic major transplantation antigens determining T-cell restriction specificity, function and responsiveness. Adv. Immunol. 27:1979;51-177.